HIV Drugs Market Rising at 6.1 % CAGR to Reach USD 40,675.0 Million by 2026; Growing Emphasis on Research and Development of Efficient Drugs to Enable Growth, says Fortune Business Insights

Key Companies Covered in the HIV Drugs Market Research Report Are ViiV Healthcare, Gilead Sciences, Inc., Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Theratechnologies Inc., Mylan Pharmaceuticals Inc., Genentech, Inc., AbbVie Inc. and other key market players.

Pune, Sept. 03, 2020 (GLOBE NEWSWIRE) — The global HIV Drugs Market is likely to derive growth form the increasing prevalence of the disease across the world. According to a report published by Fortune Business Insights, titled “HIV Drugs Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 25,314.0 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 40,675.0 Mn by 2026, thereby exhibiting a CAGR of 6.1% in the forecast period

The increasing awareness regarding the severity of HIV AIDS as created a huge emphasis on several drugs, related to the treatment of this disease. The side effects of HIV/AIDS have led to several drug innovations, particularly aimed at efficient treatment of patients with advanced stages of the disease.

Highlights of the Report:

  • Analysis of the impact of Covid-19 that the market would face in the near future.

  • In-depth analysis of the growth drivers and obstacles.

  • Profile of all the companies operating in the market.

  • Elaborate data about the dominating region.

  • Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hiv-aids-drugs-market-101115


Increasing Drug Approvals Will Enable Market Growth

The increasing emphasis on the research and development of HIV/AIDS drugs has led to several drug innovations in recent years. The increasing demand for therapeutic procedures and treatment methods has created a subsequent emphasis on the development of related drugs.

Fortune Business Insights has predicted that the increasing emphasis on HIV/AIDS treatment will encourage regulatory authorities to approve the usage of proposed drugs. Fortune Business Insights has identified growing regulatory approvals as one of the primary growth stimulators that have constituted a substantial amount of global HIV Drugs Market value in recent years.

In April 2019, the Food and Drug Administration (FDA) passed an approval for the Dovato, a drug aimed at treatment of treatment of HIV-1 in patients with no antiretroviral (ARV) treatment history. In June 2018, the Food and Drug Administration passed an approval for Merck’s Delstrigo for the treatment of HIV-1. Fortune Business Insights has predicted that major drug approvals will have a direct impact on the global HIV Drugs Market in the forthcoming years. The report encompasses several drug approvals of recent years.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.


To get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/hiv-aids-drugs-market-101115


Increasing Prevalence of HIV/AIDS will Create Growth Opportunities

The rising prevalence of HIV/AIDS has resulted in increasing emphasis on the development of treatment methods and drugs associated with the treatment of this disease. According to data published by the Joint United Nations Program in 2018, around 37.9 million people in the world are diagnosed with HIV/AIDS. Among the 37.9 million people, around 23.3 million people were undergoing antiretroviral therapy.

Due to the increasing incidence of HIV/AIDS across the world, the HIV/AIDS drugs companies have witnessed massive growth opportunities in recent years. The large patient pool will offer a huge potential for growth of several companies in the market, which in turn, will have a direct impact on the global HIV Drugs Market in the forthcoming years. The report includes several factors that constituted an increase in the global HIV/AIDS market value in recent years.

Fortune Business Insights has profiled a few of the prominent companies that have contributed to the growth of the global HIV Drugs Market in recent years. Besides, Fortune Business Insights identifies some of the key strategies adopted by a few of these companies.


Quick Buy –  HIV Drugs Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101115


Some of the leading companies that are operating in the global HIV Drugs Market:

  • ViiV Healthcare

  • Gilead Sciences, Inc.

  • Merck Sharp & Dohme Corp.

  • Bristol-Myers Squibb Company

  • Janssen Pharmaceuticals, Inc.

  • Theratechnologies Inc.

  • Mylan Pharmaceuticals Inc.

  • Genentech, Inc.

  • AbbVie Inc.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hiv-aids-drugs-market-101115


HIV Drugs Market Segmentations:

By Drug Class       

•              Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

•              Integrase Inhibitors

•              Combination HIV Medicines

•              Others

By Distribution Channel   

•              Hospital Pharmacies

•              Retail Pharmacies

•              Online Pharmacies

•              Others

By Geography      

•              North America (the USA and Canada)

•              Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

•              Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

•              Rest of the World


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/hiv-aids-drugs-market-101115


Have a Look at Related Reports:

Mobility Scooter Market Share & Industry Analysis, By Wheels (3 Wheels, 4 Wheels, and Others) End-user (Personal User and Institutional User) and Regional Forecast, 2019-2026

Foley Catheter Market Share & Industry Analysis, By Product Type (Two-way, Three-way, and Four-way), By Material (Latex, and Silicone), By Application (Urinary Incontinence, Benign Prostatic Hyperplasia, Surgery, and Others) By End User (Hospitals & Specialty Clinics, and Long-term Care Centers) and Regional Forecast, 2019-2026

Incontinence Care Products Market Share & Industry Analysis, By Product Type [Non-Absorbents (Catheters, Slings, Drainage Bags, Stimulation Devices, and Others) and Absorbents (Underwear & Briefs, Drip Collectors & Bed Protectors, and Pads & Guards)], By Gender (Male and Female), By Usage (Reusable and Disposable), By Distribution Channel (Institutional Sales, Retail Stores, and Online Channels) and Regional Forecast, 2019-2026

Pressure Ulcer Treatment Market Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026

Stomach Cancer/Gastric Cancer Treatment Market Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecast, 2019-2026

Deep Brain Stimulation (DBS) Devices Market Share & Industry Analysis, By Product Type (Dual Channel Deep Brain stimulators, Single Channel Deep Brain Stimulators), By Application (Parkinson’s Disease, Dystonia, Essential Tremor, Others), By End User (Hospitals, Specialty Clinics, Others) and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs


Press Release: https://www.fortunebusinessinsights.com/press-release/hiv-aids-drugs-market-9223